Although it is not absolutely clear whether phytol or phytol pyrophosphate is the immediate precursor of the phytylated porphyrin our experiments suggest that it is probably phytol. Both [U-14C] From these experiments it seems therefore that phytol pyrophosphate is incorporated into chlorophyll and that it exerts control over its own formation by feedback inhibition of mevalonate kinase. and over the formation of protochlorophyllide by stimulating the utilization of 6-aminolaevulinate.
Although it is not absolutely clear whether phytol or phytol pyrophosphate is the immediate precursor of the phytylated porphyrin our experiments suggest that it is probably phytol. Both [U-14C]phytol and [U-14C]phytol pyrophosphate have been found to be incorporated into chlorophyll by preparations from greening leaves of Phaseolus vulgaris. Whereas the presence of exogenous unlabelled phytol decreased the incorporation of [U-14C]phytol pyrophosphate into chlorophyll by such preparations, addition of unlabelled phytol pyrophosphate resulted in a marked increase in the incorporation of [U-14C]phytol into chlorophyll.
It appears likely that the concentration of phytol pyrophosphate exerts some control over the formation of the porphyrin moiety of chlorophyll, for addition of phytol pyrophosphate to incubation mixtures incorporating 6-arnin0[4-'~C]laevulinate into chlorophyll resulted in a marked increase in the level of incorporation.
It also appeared likely that there exists a reciprocal effect of the porphyrin moiety on the utilization of phytol for chlorophyll formation, for addition of exogenous unlabelled aminolaevulinate markedly stimulated the incorporation of both [l-14C] An alkaline proteinase was previously purified from rat skeletal muscle (Holmes et al., 1971) . It hydrolyses acetyl-L-tyrosine ethyl ester and benzoyl-L-tyrosine ethyl ester but not benzoyl-L-arginine ethyl ester; in these respects it is like chymotrypsin and unlike trypsin. Its molecular weight, determined by gel filtration, is approximately 25000. The enzyme only just entered the gels when submitted to electrophoresis on polyacrylamide gels under the following conditions [7.5 % (w/v) acrylamide, unless stated otherwise] : continuous system (pH9.2) with and without 8M-urea; continuous [pH9.2, 5 % (w/v) acrylamide] with and without 8M-urea; continuous (pH7.0); continuous (pH8.6); discontinuous (pH 8.3); discontinuous (pH4.5, electrodes reversed). This is possibly due to non-specific adsorption or to its insolubility at low ionic strengths.
The proteinase resembles in many respects the chymotrypsin-like proteinase found in peritoneal mast cells (Lagunoff & Benditt, 1963) and recently purified (Kawiak et al., 1971) . Skeletal muscle contains small numbers of mast cells situated in the connective tissue (Selye, 1965) . To ascertain whether the muscle proteinase is contained in these, rats were injected with compound 48/80 (a polymer of N-methylhomoanisylamine and formaldehyde), which causes degranulation of mast cells. An increasing daily dose was injected, as applied by Pastan & Almqvist (1966) who used this procedure to 537th MEETING, CANTERBURY demonstrate that the alkaline proteinase (thyroglobulin substrate) in homogenates of thyroid and certain other tissues was derived from mast cells. The activity of the alkaline proteinase (casein substrate) was determined in homogenates of the extensor digitorum muscle from such animals ( Table 1 ). The rate of autolytic breakdown of the homogenate protein at pH8.0 was also measured (Table 2) ; the homogenates were first dialysed overnight against O.O~M-KCI to decrease the blank values. In addition, certain other enzyme activities associated with protein breakdown were measured (Table 1) . These were acid proteinase (pH 3.5, substrate haemoglobin), leucine aminopeptidase (pH 8.2, substrate L-leucine amide) and arylamidase (pH7.3, substrate Lleucinep-nitroanilide). The relationship between the last two activities has not yet been clarified in muscle, but in some tissues, at least, they appear to be separate enzymes (Patterson et al., 1963; Marks, 1968) . The presence of 'leucine aminopeptidase' in rat mast cells has been reported (Braun-Falco & Salfeld, 1959) ; the substrate used was, however, leucine 8-naphthylamide, hence the enzyme observed was probably arylamidase. The alkaline proteinase activity (casein substrate) of thyroid homogenates was also measured, for comparison with the results of Pastan & Almqvist (1966) ; the activity was always less than 15 % of normal, following the drug treatment.
It is clear that treatment with this drug causes loss of most of the alkaline proteinase Vol. 1 activity (casein substrate) of the homogenates, which is therefore considered to originate from the mast cells. The greater part of the autolytic activity is also lost. The drug added in uitro did not inhibit the enzyme activities. Muscle homogenate from drug-treated rats did not inhibit the autolytic activity of homogenate from untreated animals.
Goldspink et al. (1971~) observed increased alkaline proteinase activity/mg of noncollagen protein (with casein as substrate) in denervated extensor digitorum and soleus muscles of rats; the activity/whole muscle was not significantly changed. It now seems probable that this is due to a relative constancy in the total number of mast cells in the atrophied muscle. Increased autolytic activity has been found in muscle preparations from vitamin E-deficient rats and hamsters (Koszalka et al., 1961) , mice with hereditary muscular dystrophy (Berlinguet & Srivistava, 1966) , rats after denervation (Kohn, 1965) , and rats fed on a protein-free diet (Millward, 1971) . The contribution of mastcell proteolytic activity may be important in relation to these changes. A higher concentration of mast cells is seen in muscle of genetically dystrophic mice (Bois, 1964) .
The activity remaining after treatment with the drug may be, at least partly, derived from the muscle fibres, although this has yet to be established. It is possible, moreover, that other proteinases may be present in muscle homogenates but may be inhibited by plasma anti-proteinases arising from the extracellular space and entrapped blood (Goldspink et al., 1971b) .
The activities of acid proteinase, leucine aminopeptidase and arylamidase were within normal limits after treatment with the drug.
Attempts were made to ascertain the intracellular location of the alkaline proteinase by differential centrifugation and density gradient centrifugation of muscle homogenates. On differential centrifuging the proteinase was present in the low-speed deposit (600g, l0min) containing predominantly myofibrils. In density-gradient experiments using a sucrose gradient (35-80 %, w/v, 63 500g, 2 h) the proteinase was recovered in a dense band containing the myofibrils. The distribution of the proteinase among the fractions did not parallel that of either succinate dehydrogenase or acid proteinase, thus indicating that it is not associated with mitochondria or lysosomes.
Various attempts were made to dissociate the proteinase from the myofibril fraction. Both Potter-Elvehjem and Ultra-Turrax homogenizers were used and the time and speed of the treatment were varied. Samples of low-speed deposit were suspended in buffers, pH5 and 10, and recentrifuged at low speed; the enzyme remained with the deposit. Density-gradient centrifugation of a sample of low-speed deposit which had been sonicated gave the same pattern as an untreated sample. Addition of heparin to the homogenizing medium slowed the sedimentation of both the proteinase and the myofibrils. Incubation of the homogenate with compound 48/80 (0.8pglml) for 1 h at room temperature did not affect the distribution of the enzyme. It would appear that the enzyme is either attached to a cell fragment which sediments with the myofibrils or has become adsorbed on the latter. Two approaches to the therapy of inherited enzyme deficiencies in man involve replacement of the missing enzyme, or replacement of the faulty DNA sequence normally transcribing for the enzyme. In both approaches, therapeutic substances designed to replace those that are missing or malfunctioning are required to reach and act in the cells where the enyzme function is important. However, enzymes or DNA fragments injected into the circulation can provoke immunological reactions, be incompatible with blood or vulnerable to blood enzymes, be taken up by the reticuloendothelial system or non-diseased tissues, or be unable to reach or penetrate target tissues. These problems might be circumvented by the entrapment of therapeutic substances into a general carrier which would not only protect its contents from the environment and vice versa but also, owing to its surface properties, direct its contents to a target tissue, and facilitate uptake by diseased cells while the carrier itself is digested or otherwise eliminated.
Liposomes, consisting of concentric lipid bilayers alternating with aqueous compartments within which water-soluble substances can be entrapped (Bangham, 1968) , satisfy some of the requirements for such a carrier (Gregoriadis et al., 1971 ; Gregoriadis & Ryman, 1971 , 1972a Magee & Miller, 1972) . Experiments in viuo with enzymecontaining liposomes (Gregoriadis & Ryman, 1971 , 1972a have shown that following injection of such liposomes into rats, liposonial enzyme activity remains latent while in the circulation and is eventually recovered in hepatic lysosomes. The carriage of an enzyme by liposomes into cell lysosomes could be applicable to the treatment of storage diseases in which the absence of a specific enzyme activity (usually lysosomal) in one or more tissues leads to the deposition of undigested substrates in the lysosomes of these tissues. It therefore seemed appropriate to test the therapeutic efficiency of liposomes as enzyme carriers in a model storage condition. Exposure of mouse peritoneal macrophages (Cohn & Ehrenreich, 1969) and Chinese-hamster fibroblasts (Nyberg & Dingle, 1970) to sucrose results in the accumulation of sucrose in the lysosomes, which then appear as phase-lucent vacuoles in the perinuclear region of the cells. Exposure of such cells to free /%fructofuranosidase results in the elimination of these vacuoles owing to the hydrolysis of stored sucrose by pinocytosized /%fructofuranosidase (Cohn & Ehrenreich, 1969) .
We have investigated the effect of liposomes containing /3-fructofuranosidase on sucrose-loaded cultured cells. Liposomes used here were composed of phosphatidylcholine, cholesterol and phosphatidic acid (7 : 2:l molar proportion). Unstimulated mouse peritoneal macrophages were grown in plastic Petri dishes (1.2 x 106-2.5 x lo6 cells/dish) each containing 3-4 cover slips and 4ml of medium 199 supplemented with 20% foetal calf serum, 100 units each of penicillin and streptomycin/ml and 0.11 % NaHC03 (complete medium). In a typical experiment cells in six dishes were exposed to lOmg of sucrose/ml of medium, and cells in two dishes (serving as controls) were exposed to completemedium only. A11 dishes weregassed with air+C02 (90:lO) and incubated at 37°C. Then 24h later the media were withdrawn and the cell sheets washed
